Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: ASA I-II patients scheduled to undergo elective modified radical mastectomy
Exclusion criteria
Exclusion criteria: 1) Patient refusal for regional techniques 2) All contra-indications to regional techniques: a) Local or systemic infection b) Known allergy to the study drugs c) Bleeding disorders d) Platelet count 3) BMI > 35 4) Inability to use PCA device post operatively
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 24-hour fentanyl consumptionTimepoint: From arrival in post-anesthesia care unit to 24 hours post-operatively | — |
Secondary
| Measure | Time frame |
|---|---|
| Incidence of adverse events (Post-operative nausea/vomiting, respiratory depression, pruritus, urinary retention)Timepoint: From arrival in post-anesthesia care unit to 24 hours post-operatively;Patient satisfaction scoreTimepoint: At 24 hours after operation;Post-operative pain parameters: 0-100mm Visual analogue scale (VAS) on abduction of ipsilateral arm above the headTimepoint: At the time of arrival in post-anesthesia care unit and then at 30 minutes, 1, 2, 4, 6, 12 and 24 hours after operation.;Time to first analgesic requirementTimepoint: From arrival in post-anesthesia care unit to 24 hours post-operatively | — |
Countries
India
Contacts
All India Institute of Medical Sciences, New Delhi